| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 10/14/2004 | WO2004015130A3 Modulators of rabggt and methods of use thereof |
| 10/14/2004 | WO2003104475A3 Atm related kinase atx, nucleic acids encoding same and methods of use |
| 10/14/2004 | WO2003099233A3 Microbial conversion of glucose to para-hydroxystyrene |
| 10/14/2004 | WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/14/2004 | WO2003052057A3 Egvi endoglucanase and nucleic acids encoding the same |
| 10/14/2004 | WO2001094377A3 Metalloprotease peptide substrates and methods |
| 10/14/2004 | WO2001075067A8 Novel nucleic acids and polypeptides |
| 10/14/2004 | US20040205847 Vector comprising nucleotide sequences coding glyphosate resistance-conferring decarboxylase gene (GDC-1) for use in the generation of herbicide resistant plants; tissue engineering |
| 10/14/2004 | US20040205845 Chimeric potato comprising vector expressing sequences which reduce or inhibit adenylate kinase activities thereby enhancing starch accumulation; tissue engineering |
| 10/14/2004 | US20040205844 Preparation of heterologous proteins on oil bodies |
| 10/14/2004 | US20040205843 Geminivirus resistant transgenic plants |
| 10/14/2004 | US20040205835 Jak kinases and regulation of cytokine signal transduction |
| 10/14/2004 | US20040204863 Crystal of a kinase-ligand complex and methods of use |
| 10/14/2004 | US20040204595 preferably (3 alpha ,3a beta ,6a beta )-hexahydrofuro[2,3-b]furan-3-ol; preparation of an oxetane intermediate by means of a photochemical cycloaddition reaction |
| 10/14/2004 | US20040204579 Comprises starch synthase for use in enhancing digestibility of food stuffs, paper processing, adhesives and textile processing |
| 10/14/2004 | US20040204577 Novel peptide-forming enzyme gene |
| 10/14/2004 | US20040204576 Polynucleotides encoding a novel human phosphatase, BMY_HPP13 |
| 10/14/2004 | US20040204563 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors |
| 10/14/2004 | US20040204381 method of treating brain cancer in which tumor cell is transfected either ex vivo or in vivo with a composition comprising a DNA molecule that encodes a protein having glycosyltransferase activity resulting in inhibition of the growth or function of that cell |
| 10/14/2004 | US20040204364 Peptides for activation and inhibition of deltaPKC |
| 10/14/2004 | US20040204348 Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040204338 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action |
| 10/14/2004 | US20040203132 Conus protein disulfide isomerase |
| 10/14/2004 | US20040203131 diagnosis of transmissible spongiform encephalopathies (TSEs) especially in an immunoassay, as well as its use as an immunogen; genetic engineering |
| 10/14/2004 | US20040203130 Subtilisin variants |
| 10/14/2004 | US20040203129 having high specific activity and strong oxidant resistance, and having excellent detergency that is to be added to a detergent |
| 10/14/2004 | US20040203128 Use of PP2A phosphatase modulators in the treatment of mental disorders |
| 10/14/2004 | US20040203127 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/14/2004 | US20040203125 recombinant chimera produced using solid phase synthesis; for biosnesors/bioreactors, diagnostic and drugs |
| 10/14/2004 | US20040203113 Nucleic acids encoding beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni |
| 10/14/2004 | US20040203112 Beta1,4-N-acetylgalactosaminyltransferases from C. jenuni |
| 10/14/2004 | US20040203111 UDP-N-acetylglucosamine: galactose-B1,3-N-acetylgalactosamine-a-R/ (GlcNAc to GalNAc) B1-6 N- acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203108 use as a carrier for a conjugate, particularly in combination with a polysaccharide, and a process for producing the peptide as well as vaccines comprising said peptide |
| 10/14/2004 | US20040203107 Methods and compositions for grafting functional loops into a protein |
| 10/14/2004 | US20040203105 for drug screening emzyme inhibitors using genetically engineered animal models; for anticancer agents |
| 10/14/2004 | US20040203104 for drug screening enzyme inhibitors; genetic engineering; comprising subjecting the sample to a polymerase chain reaction, a northern hybridization assay or an in situ hybridization assay |
| 10/14/2004 | US20040203103 has both an alpha 2,3- and an alpha 2,8-activity; involved in synthesis of lipooligosaccharide (LOS); genetic engineering |
| 10/14/2004 | US20040203102 Antiplasmin cleaving enzyme |
| 10/14/2004 | US20040203098 Compounds and methods for modulating activation of NF-kappaB |
| 10/14/2004 | US20040203097 Kinases and phosphatases |
| 10/14/2004 | US20040203096 performed in vitro; for treatment of type II glycogen storage disease in mammals, including humans; genetic engineering |
| 10/14/2004 | US20040203095 from porcine pancreas in pichia pastoris which is soluble and secreted into the culture medium, whereby expression at pH 3.0-4.0 substantially prevents activation of trypsinogen to beta -trypsin and autolysis of beta-trypsin by alpha -trypsin |
| 10/14/2004 | US20040203094 Eucyl-tRNA synthetases and derivatives thereof that activate and aminoacylate non-leucine amino acids to tRNA adaptor molecules |
| 10/14/2004 | US20040203092 UDP-N-acetylglucosamine:galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203087 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 10/14/2004 | US20040203059 Novel human proteases and polynucleotides encoding the same |
| 10/14/2004 | US20040203058 Novel human kinase and polynucleotides encoding the same |
| 10/14/2004 | US20040203042 Comprises nucleotide sequences coding beta -site amyloid precursor protein cleaving enzyme (BACE) for identifying modulator for prevention and treatment of dimentias associated with amyloid plaque accumulation |
| 10/14/2004 | US20040203030 for drug screening cyclooxygenases for use in conditions including cell proliferation, inflammatory/immune responses, smooth muscle contraction, maintenance of fluid/electrolyte balance, platelet aggregation, production of extracellular matrix proteins |
| 10/14/2004 | US20040203015 comprises cell which produces megosamine and can attach megosamine to a polyketide; includes genes of the mycarosyl/desosamine biosynthesis pathway and transferase |
| 10/14/2004 | US20040202649 Identification of the MECA-79 antigen and related methods of treating L-selectin-mediated conditions |
| 10/14/2004 | US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy |
| 10/14/2004 | US20040202644 Crystallization and structure of Staphylococcus aureus peptide deformylase |
| 10/14/2004 | US20040202643 capable of change from insoluble and stable form to soluble and active form upon a change in temperature, pH, chemical composition, concentration, and/or change in shear force acting upon the crystal; capable of releasing their protein activity at a controlled rate |
| 10/14/2004 | DE10295684T9 Verfahren zum spezifischen Hemmen von Histon-Deacetylase-4 Method for the specific inhibition of histone deacetylase 4 |
| 10/14/2004 | CA2521141A1 Method for the enrichment of target cells by use of cbds |
| 10/14/2004 | CA2520795A1 Novel plant acyltransferases specific for long-chained, multiply unsaturated fatty acids |
| 10/14/2004 | CA2520532A1 Polynucleotide encoding 2-hydroxyisoflavanone dehydratase and use thereof |
| 10/14/2004 | CA2520479A1 Method and system for rapidly conferring a desired trait to an organism |
| 10/14/2004 | CA2520396A1 Pufa polyketide synthase systems and uses thereof |
| 10/14/2004 | CA2520381A1 Proteolytic and covalent antibodies |
| 10/14/2004 | CA2520170A1 Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity |
| 10/14/2004 | CA2519309A1 Dna polymerase fusions and uses thereof |
| 10/13/2004 | EP1466982A1 Pyroglutamyl peptidase and its gene |
| 10/13/2004 | EP1466981A1 Glycosyle hydrolyse genes and uses thereof for the biodegradation of carraghenane |
| 10/13/2004 | EP1466980A1 Lipase and use of same for improving doughs and baked products |
| 10/13/2004 | EP1466979A1 Fungus-origin lysyl oxidases |
| 10/13/2004 | EP1466971A1 Preparation of lactams from aliphatic alpha,omega dinitriles |
| 10/13/2004 | EP1466970A1 Alkaline protease |
| 10/13/2004 | EP1466969A1 Sulfated fucan |
| 10/13/2004 | EP1466962A1 Alkaline protease |
| 10/13/2004 | EP1466886A2 New salts of HMG-CoA reductase inhibitors |
| 10/13/2004 | EP1466624A1 Drug for regenerating tissue and vessel and method therefor |
| 10/13/2004 | EP1466529A1 Composition with heart rate reducing properties |
| 10/13/2004 | EP1466174A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 10/13/2004 | EP1466013A2 Thermus scotoductus nucleic acid polymerases |
| 10/13/2004 | EP1466005A1 Carbohydrate-associated proteins |
| 10/13/2004 | EP1465993A2 Inducible transposition in transgenic organism using transposon vector |
| 10/13/2004 | EP1465990A2 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 10/13/2004 | EP1465988A2 Myo-inositol oxygenases |
| 10/13/2004 | EP1465985A2 High level cytokine production with enhanced cell viability |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465908A2 Compositions and methods for hydroxylating epothilones |
| 10/13/2004 | EP1465897A2 Process for preparing protease inhibitor intermediates |
| 10/13/2004 | EP1465659A2 Use of a novel cell surface protease from group b streptococcus |
| 10/13/2004 | EP1465655A1 Microbially-expressed thermotolerant phytase for animal feed |
| 10/13/2004 | EP1465651A1 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer |
| 10/13/2004 | EP1465481A1 Knockout swine and methods for making the same |
| 10/13/2004 | EP1404862A4 Thermostable proteinases from thermophilic bacteria |
| 10/13/2004 | EP1335930B1 Process for the preparation of 3-oxo-4-azasteroids |
| 10/13/2004 | EP1280820B1 Anti-inflammatory compounds and uses thereof |
| 10/13/2004 | EP1230374A4 Modification of polysaccharide containing materials |
| 10/13/2004 | EP1087786B1 Methods and materials for the treatment of prostatic carcinoma |
| 10/13/2004 | EP1062230B1 Method for increasing the serum half-life of a biologically active molecule |
| 10/13/2004 | EP1038018A4 Aldol condensations by catalytic antibodies |
| 10/13/2004 | EP0918851B1 Expression system for altered expression levels |
| 10/13/2004 | EP0897423B1 Alkaline lipolytic enzyme |
| 10/13/2004 | EP0851933B1 Plant gene encoding acetyl coenzyme a carboxylase biotin carboxylase carrier protein |
| 10/13/2004 | CN1537168A Increase in vitamin E content in organisms due to increase in tyrosine aminotransferase |